Literature DB >> 7825851

Preclinical exploration of the potential antiinflammatory properties of the peptide leukotriene antagonist ICI 204,219 (Accolate).

R D Krell1, C J Dehaas, D J Lengel, E J Kusner, J C Williams, C K Buckner.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7825851     DOI： 10.1111/j.1749-6632.1994.tb52746.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN： 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  5 in total

Review 1.  Zafirlukast: an update of its pharmacology and therapeutic efficacy in asthma.

Authors:  C J Dunn; K L Goa
Journal:  Drugs       Date:  2001       Impact factor: 9.546

Review 2.  G Protein-Coupled Receptors in Asthma Therapy: Pharmacology and Drug Action.

Authors:  Stacy Gelhaus Wendell; Hao Fan; Cheng Zhang
Journal:  Pharmacol Rev       Date:  2020-01       Impact factor: 25.468

Review 3.  Zafirlukast. A review of its pharmacology and therapeutic potential in the management of asthma.

Authors:  J C Adkins; R N Brogden
Journal:  Drugs       Date:  1998-01       Impact factor: 9.546

Review 4.  Childhood asthma: causes, epidemiological factors and complications.

Authors:  D J Valacer
Journal:  Drugs       Date:  2000       Impact factor: 9.546

Review 5.  Pharmacokinetic profile of zafirlukast.

Authors:  P N Richard Dekhuijzen; Peter P Koopmans
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.